Daniele Zink,
Principal Research Scientist and Team Leader, Institute of Bioengineering and Nanotechology
Daniele Zink earned her PhD from the University of Heidelberg, Germany in 1995, and was appointed in 1996 as Research Assistant Professor at the Ludwig-Maximilians University (LMU), Munich, Germany. In 2001 she completed her Habilitation in Cell Biology and was awarded funding of a Junior Group from the Volkswagen-Foundation. She was head of the Junior Group at the LMU until she was appointed in 2007 as Team Leader and Principal Research Scientist by the Institute of Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research in Singapore. Her research focuses on stem cells and predictive methods for in vitro toxicology/nanotoxicology. This work has been awarded by the US Society of Toxicology and Zink has won the prestigious LUSH Prize (2016, Science Category). Zink is co-founder of the spin-off Cellbae that is specialized on stem cell products and applications, holds 12 patents/patent applications, is Editorial Board Member of Scientific Reports and has > 70 publications, which include publications in Nature, Nature Reviews Cancer, Archives of Toxicology and Nanotoxicology.
|
|
|
